Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Department of Pathology and Laboratory Medicine, |
RCV000501173 | SCV000592797 | pathogenic | Autosomal recessive polycystic kidney disease | criteria provided, single submitter | clinical testing | ||
Cavalleri Lab, |
RCV001095637 | SCV001251278 | pathogenic | Polycystic kidney disease, adult type | 2020-02-05 | criteria provided, single submitter | research | PVS1, PM2, PP4 |
Centre for Mendelian Genomics, |
RCV001095637 | SCV001368016 | pathogenic | Polycystic kidney disease, adult type | 2016-01-01 | criteria provided, single submitter | clinical testing | This variant was classified as: Pathogenic. |
Molecular Genetics of Inherited Kidney Disorders Laboratory, |
RCV001249167 | SCV001422372 | pathogenic | not provided | 2019-01-01 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV001095637 | SCV002802647 | pathogenic | Polycystic kidney disease, adult type | 2021-07-17 | criteria provided, single submitter | clinical testing | |
Eurofins- |
RCV001095637 | SCV003935046 | pathogenic | Polycystic kidney disease, adult type | 2022-10-24 | criteria provided, single submitter | clinical testing | |
Neuberg Centre For Genomic Medicine, |
RCV001095637 | SCV004100656 | pathogenic | Polycystic kidney disease, adult type | criteria provided, single submitter | clinical testing | The frameshift duplication p.V2334Gfs*88 in PKD1 (NM_001009944.3) has been reported to ClinVar as Pathogenic by multiple laboratories.The p.V2334Gfs*88 variant is novel (not in any individuals) in gnomAD Exomes and is novel (not in any individuals) in 1000 Genomes. This variant is predicted to cause loss of normal protein function through protein truncation. For these reasons, this variant has been classified as Pathogenic. | |
Juno Genomics, |
RCV001095637 | SCV005184190 | pathogenic | Polycystic kidney disease, adult type | 2024-07-19 | criteria provided, single submitter | clinical testing | PM2_Supporting+PVS1+PS4_Moderate+PP4 |
Center for Genomic Medicine, |
RCV001095637 | SCV005374427 | pathogenic | Polycystic kidney disease, adult type | 2024-09-22 | criteria provided, single submitter | clinical testing | |
Genomics England Pilot Project, |
RCV001095637 | SCV001760369 | pathogenic | Polycystic kidney disease, adult type | no assertion criteria provided | clinical testing |